E8-19946. Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Centers for Birth Defects Research and Prevention, Funding Opportunity Announcement (FOA) DD09-001

In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting.

Time and Date: 9 a.m.-2 p.m., October 7, 2008 (Closed).

Place: Centers for Disease Control and Prevention, Global Communications Center, 1600 Clifton Road, NE., Atlanta, GA 30333, 404-639-3138.

Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.

Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of applications received in response to “Centers for Birth Defects Research and Prevention, FOA DD09-001.”

Contact Person for More Information: Susan Stanton, D.D.S., Scientific Review Officer, Office of the Chief Science Officer, CDC, 1600 Clifton Road, NE., Mailstop D74, Atlanta, GA 30333, Telephone [phone].

The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.

Dated: August 22, 2008.

Elaine L. Baker,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.